Twist Bioscience Corporation

February 07, 2026 • Author: Phil Ratcliff

Item	Proposal	Vote
1	Vote Board of Directors:
1.1	Election of Director: Keith Crandell	✓ For(23.000)
1.2	Election of Director: Jan Johannessen	✓ For(23.000)
1.3	Election of Director: Trynka Shineman Blake	✓ For(23.000)
2	To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."	✓ For(23.000)
3	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026.	✓ For(23.000)

Attachments

📄

Twist_Bioscience_10k.pdf 1.1 MB

📄

Twist_Bioscience_Proxy_Statement.pdf 0.9 MB

This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.